Company / Operating Margin
Lexaria Bioscience Corp. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1239.2%
FY2025
5-year range
-2888.5% / -786.9%
FY2021-FY2025
Trend
+57.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin returned to growth in FY2025 after 2 years of decline, reaching -1239.2%.
Based on SEC 10-K filings.
-1239.2% in FY2025 with a 3-year CAGR of -452.3%.
Improved from -2591.7% to -1239.2% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -452.3pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 57.1% year-over-year.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1239.2% | +57.1% |
| FY2024 | -2888.5% | -11.5% |
| FY2023 | -2591.7% | -229.4% |
| FY2022 | -786.9% | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | -13489.8% | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026